The phosphatidylinositide 3 (PI3)-kinase/mechanistic target of rapamycin (mTOR) pathway has recently been described as a critical driver of oncogenesis in ALL [22–25]. This evidence concerns the gene MTOR and acute lymphoblastic leukemia.